Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery

Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery

NCT01066351 ·Status: UNKNOWN ·Phase: PHASE3

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia

NCT03528564 ·Status: TERMINATED ·Phase: PHASE2

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

NCT06053866 ·Status: NOT_YET_RECRUITING

Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction

NCT00367991 ·Status: COMPLETED ·Phase: PHASE2

Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery

NCT01393418 ·Status: COMPLETED

Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients

NCT00204334 ·Status: COMPLETED ·Phase: PHASE4

Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery

NCT02984111 ·Status: COMPLETED ·Phase: NA

Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty

NCT03917394 ·Status: UNKNOWN

A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)

NCT00270114 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients

NCT03867071 ·Status: COMPLETED ·Phase: NA

Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation

NCT00425698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

NCT00368238 ·Status: COMPLETED ·Phase: PHASE2

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

NCT00396435 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

NCT00270062 ·Status: COMPLETED ·Phase: PHASE3

Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia

NCT00954486 ·Status: WITHDRAWN ·Phase: NA

Erythropoietin to Improve Critical Care Patient Outcomes

NCT05080049 ·Status: UNKNOWN ·Phase: PHASE3

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.

NCT02987465 ·Status: COMPLETED

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

NCT01290328 ·Status: TERMINATED ·Phase: NA

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

NCT01546337 ·Status: TERMINATED

A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.

NCT00270179 ·Status: COMPLETED ·Phase: PHASE3

Effect of the Combined Programme on Perioperative Anaemia（CPPA）

NCT05353348 ·Status: RECRUITING ·Phase: NA

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144495 ·Status: COMPLETED ·Phase: PHASE3

Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

NCT02496377 ·Status: COMPLETED ·Phase: NA

A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

NCT00269971 ·Status: WITHDRAWN ·Phase: PHASE3